FILTER

FILTERED INTERVIEW RESULTS

Eric Smith

MANAGING DIRECTOR, CEMENTATION AMERICAS
"We are optimistic about long-term opportunities in both Ontario and the Western US. Our strategy centers around developing and maintaining capacity and preparing for when projects start flowing in."

Paul Johnson and Bill Zisch

PRESIDENT (PJ) AND HEAD OF MINING ENGINEERING (BZ), COLORADO SCHOOL OF MINES
"The mining industry needs all types of engineers, so we are reaching out to mechanical, electrical, environmental, and computer science students as well to introduce them to career opportunities in mining."

Siva Samy

CEO & CHIEF PRODUCT STRATEGIST, VALGENESIS
"With continued investments in AI and automation, we are accelerating the industry's shift to digital validation and data-driven decision-making."

Krishna Kanumuri

CEO AND MANAGING DIRECTOR, SAI LIFE SCIENCES
"The demand for seamless phase transitions is growing, with integrated CRDMOs enabling better knowledge transfer and faster development."

Rajiv Anand

FOUNDER AND CEO, QUARTIC.AI
"Digital transformation helps accelerate drug pipelines by reducing workload and increasing efficiency."

James Stephens and Darrell Tweidt

CLIENT SERVICES MANAGERS, PREMIER DRILLING CO.
"Experienced drillers who understand the local terrain are crucial for success."

Himanshu Gadgil

CEO, ENZENE BIOSCIENCES
"From an innovation point of view, breaking the US$40/gram cost barrier for production of mAbs is a key objective this year."

George Bee

PRESIDENT AND CEO, U.S. GOLD CORP
"Our permitted status positions us favorably to capitalize on these market conditions, with the lower cost CK project production being attractive, particularly as established gold producers struggle to maintain production levels."

Mike Radomsky

PRESIDENT, CMC PHARMACEUTICALS
"We balance the need for speed in drug development with strict regulatory requirements by focusing on robust data, sound justifications and a well-structured technical package."

Andrea Confetti and Roberto Fanelli

EXCLUSIVE SYNTHESIS BU LEADER (AC) & CATALOGUE APIS BU LEADER (RF), DIPHARMA FRANCIS
"Small molecule drugs dominate pharmaceutical development, holding almost 60% of the market in 2024, and FDA approvals for small molecules are expected to stay strong."

MACIG

SPANISH

SUBSCRIBE TO OUR NEWSLETTER

RECENT PUBLICATIONS

United States Life Sciences 2025 - Digital Interactive

Resilience amid uncertainty. These words encapsulate the US life sciences sector as it navigates 2025. While the industry has largely rebounded from the recent biotech bear market, with clinical trial starts and funding showing signs of rebound, headwinds remain.

PARTNER EVENTS